Dr. Muhammad Sohaib Afzal, MD

Dr. Afzal practices at Ochsner Lsu Health Shreveport in Shreveport, Louisiana.

Dr. Afzal's NPI, 1053807222, was assigned on July 10, 2018. Dr. Afzal graduated from Quaid-e-Azam Medical College in 2013. Dr. Afzal holds Louisiana license 327233.

Dr. Afzal's primary practice is Ochsner Lsu Health Shreveport, at 1541 Kings Hwy, Shreveport, LA 71103 in Caddo Parish. The practice phone is (318) 626-0000.

Dr. Afzal's primary practice is Ochsner Lsu Health Shreveport in Shreveport, Louisiana. The medical group on file is LSU Health Shreveport.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Afzal practices. Vendor and product names are available with a free account.

Internal medicine is Dr. Afzal's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Afzal is licensed in Louisiana.

Dmand AI lists acute diabetes, anemia, congestive heart failure, heart attack, high cholesterol, kidney failure, non-surgical back problems and seizures among the conditions Dr. Afzal treats.

CMS data shows 459 Medicare services from Dr. Afzal across 4 procedure codes in 2024, for 151 Medicare patients. Medicare paid $37,428 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 151 Medicare patients who saw Dr. Afzal in 2024. The largest group is 65 to 74, with 55 patients. 75% of them have high blood pressure, and 74% have high cholesterol. 53% are also on Medicaid. Their average risk score is 2.37, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Afzal's median patient age at 70, with 46% women.

In 2024, Dr. Afzal wrote 283 Medicare Part D claims for 70 patients. 82% of them were for generic drugs. CMS names the drug for 88 of them, across 5 drugs with 11 or more claims each, at $690 in total drug cost. In 2023, CMS named 84 claims across 6 drugs.

Dmand AI links 188 papers to Dr. Afzal, published from 2011 to 2025. 2021 was the busiest year, with 35. The most frequent topics are Pakistan, COVID-19 and SARS-CoV-2. Dr. Afzal has published most often in Acta Trop. Dr. Afzal's most frequent co-authors are Arslan Afzal, Gul Nawaz, MD and Ahtshamullah Chaudhry, MD.

CMS Open Payments shows 8 general payments to Dr. Afzal from 6 drug and device companies from 2019 to 2025. Food and beverage make up the largest share, 100% of the total. Medtronic, Inc. paid the most, $67.

Dr. Afzal graduated from Quaid-e-Azam Medical College in 2013.

Dr. Afzal is in network with 5 carriers, including Aetna, United Healthcare and Blue Cross and Blue Shield of Louisiana. Medicare plans come from the most carriers, 3. Check the plan with the practice before a visit.